Filip Y F L De Vos Selected Research

Venous Thromboembolism

1/2018

Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Filip Y F L De Vos Research Topics

Disease

3	Neoplasms (Cancer) 04/2021 - 10/2013
1	Edema (Dropsy) 01/2022
1	Exanthema (Rash) 01/2022
1	Nausea 01/2022
1	Anemia 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Fatigue 01/2022
1	Diarrhea 01/2022
1	Vision Disorders (Hemeralopia) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Breast Neoplasms (Breast Cancer) 11/2018
1	Venous Thromboembolism 01/2018
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2018
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 10/2013
1	Seminoma 10/2013
1	Neoplasm Metastasis (Metastasis) 10/2013
1	Liver Diseases (Liver Disease) 10/2013
1	Eosinophilia 10/2013
1	Pneumonia (Pneumonitis) 10/2013

Drug/Important Bio-Agent (IBA)

2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2019 - 01/2019
1	ribociclibIBA 01/2022
1	binimetinibIBA 01/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 04/2021
1	depatuxizumab mafodotinIBA 01/2021
1	Lomustine (CCNU)FDA Link 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	olaparibIBA 11/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2013

Therapy/Procedure

1	Therapeutics 11/2018
1	Craniotomy 01/2018
1	Drug Therapy (Chemotherapy) 10/2013